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Background: Tuberculosis is a major cause of childhood morbidity and mortality in Nigeria.
Diagnosis of childhood tuberculosis is a global challenge making early treatment a mirage. In this
study we investigated the stools of children for the presence of mycobacteria.
Methods: Stool samples from children aged 3 days to 3 years who presented for postnatal
immunization at a large university-based clinic in Nigeria, were subjected to Ziehl—Neelsen
staining. Samples with acid-fast bacilli were further processed using mycobacterial culture,
spoligotyping, and deletion typing.
Results: One hundred and ninety-two stool samples from different children were collected and
processed. Thirty (15.6%) had acid-fast bacilli. Of these, eight had Mycobacterium tuberculosis
and one had Mycobacterium africanum.
Conclusions: Approximately 5% (9/192) of apparently well children had evidence of potentially
serious tuberculosis infection. The usefulness of stool specimens for diagnosing pediatric
tuberculosis warrants further investigation.
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E-mail address: b-taiwo@northwestern.edu (B.O. Taiwo).
1201-9712/$36.00 # 2009 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2008.11.016Introduction
More than 2 billion people, approximately one-third of the
global population, are infected with Mycobacterium tuber-
culosis, the major causative organism of tuberculosis (TB).1Published by Elsevier Ltd. All rights reserved.
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members of the Mycobacterium tuberculosis complex, are
much less frequent causes of TB in humans. The incidence
and prevalence of pediatric TB varies significantly across the
globe, driven largely by the burden of the disease in different
countries. About 1 million children under 15 years of age
develop TB worldwide annually, representing 11% of all TB
cases.2 The majority of these cases occur in low-income
countries where the prevalence of HIV/AIDS is high.3 Nigeria
currently ranks fourth on the list of TB burdened nations
globally,1 and pediatric TB accounts for a substantial propor-
tion of these cases.4 Almost 2 million people per year die as a
result of TB, mostly in developing countries like Nigeria, but
themortality in children is often underreported. Despite this,
TB is one of the ten leading causes of childhood mortality.5
Young children and especially newborns are at a high risk
when exposed to a contagious source.6 A comprehensive
review of the natural history of childhood TB showed that
primary infection before 2 years of age frequently progressed
to active disease within 12 months.7 As such, pediatric TB is a
sentinel event reflecting recent TB transmission from an
infectious contact in the community. The number of children
with TB in a community is an indirect parameter for assessing
the effectiveness of the local TB control program.3
The diagnosis of pulmonary TB (PTB) in children is chal-
lenging.8 Children rarely expectorate adequate amounts of
sputum, and the limitations of using other specimens or
techniques, such as first morning gastric aspirates (consid-
ered the best clinical specimens for young children with
suspected PTB), nasopharyngeal swabs, sputum induction,
and laryngeal swabs, are well known. Accordingly, there is a
strong imperative to evaluate the diagnostic utility of clinical
specimens that are more readily collectable. Some investi-
gators have suggested that stool microscopy and culture for
M. tuberculosis may be diagnostic in some children with
tuberculosis,9—12 but other investigators have described stool
evaluation as ‘worthless’ since non-pathogenic acid-fast
bacilli (AFB) may be found in the normal intestinal contents
of adults.13,14
Following the identification of AFB in the stools of appar-
ently well children who were being screened for cryptospor-
idiosis in our immunization clinic, we designed this study to




Subjects were consecutive children who presented for immu-
nization at the University of Ibadan Health Services Clinic,
Ibadan, Nigeria. Stool samples from the children were eval-
uated using AFB staining. All the AFB-positive stool specimens
were evaluated further for the presence of mycobacteria.
Ethical approval
The Institutional Review Committee of the University of
Ibadan and the University College Hospital, Ibadan, Nigeria
approved the study. Oral informed consent was obtained
from the parents of the children.Clinical specimens
Stool samples were collected from each child into a sterile
plastic container and kept in the refrigerator at 4 8C prior to
processing using Ziehl—Neelsen (ZN) staining. The ZN stain
was carried out as described by Shrestha et al.15
Processing of samples
From the stool samples positive by ZN staining, 2—3 g was
suspended in 5 ml of sterile distilled water, mixed, and left
for 15 min to separate, after which 3 ml of the supernatant
was processed. Using a sterile centrifuge tube, equal
amounts of specimen and activated N-acetyl-L-cysteine
(NALC)—NaOH (3 ml each) was added. The contents of the
tube were mixed until the specimen was liquefied, and then
allowed to stand for 15 min. Phosphate buffer was added to
the 10 ml mark on the centrifuge tube and mixed, followed
by centrifugation for 15 min at 3000  g. The supernatant
was decanted; 2 ml of phosphate buffer pH 6.8 was added to
resuspend the pellet. The suspension was inoculated onto
Lowenstein—Jensen slopes with pyruvate and/or glycerol and
incubated at 37 8C for between 8 and 12 weeks. Isolates were
harvested for molecular typing analysis by scraping the
growth from slopes into 200 ml of sterile distilled water
and heating at 80 8C for 1 h.
Spoligotyping
This was carried out as previously described with minor mod-
ifications.16Thedirect repeat (DR) regionwasamplifiedbyPCR
with oligonucleotide primers derived from the DR sequence.
Twenty-five microliters of the following reaction mixture was
used for the PCR: 12.5 ml of HotStarTaq Master Mix (Qiagen;
this solution provides a final concentration of 1.5 mM MgCl2
and 200 mM each deoxynucleoside triphosphate), 2 ml of each
primer (20 pmol each), 5 ml of the suspension of heat-killed
cells (approx. 10—50 ng), and 3.5 ml of distilled water. The
mixture was heated for 15 min at 96 8C and subjected to 30
cycles of 1 min at 96 8C, 1 min at 55 8C, and 30 s at 72 8C. The
amplified product was hybridized to a set of 43 immobilized
oligonucleotides, each corresponding to one of the unique
spacerDNA sequenceswithin theDR locus.After hybridization,
the membrane was washed twice for 10 min in 2 SSPE (1
SSPE is 0.18 M NaCl, 10 mM NaH2 PO4, and 1 mM EDTA (pH
7.7))—0.5% sodium dodecyl sulfate (SDS) at 60 8C and then
incubated in 1:4000-diluted streptavidin-peroxidase conju-
gate (Boehringer) for 45 to 60 min at 42 8C. The membrane
was washed twice for 10 min in 2 SSPE—0.5% SDS at 42 8C and
rinsed with 2 SSPE for 5 min at room temperature. Hybridiz-
ing DNA was detected by the enhanced chemiluminescence
method (Amersham) and by exposure to X-ray film (Hyperfilm
ECL; Amersham) as specified by the manufacturer.
Deletion typing
The use of deletion analysis for the typing of M. tuberculosis
complex strains has been previously described.17,18 For this
work, the deletion typing method described by Warren
et al.19 was used. In our analysis, we used primers directed
against the RD4 and RD9 loci to generate a deletion profile
Table 1 Profile of pediatric patients with a positive culture result for Mycobacterium species
ID Sex Age SpolDB4 type Family in SpolDB4 type Species
JC1 F 2 months 52 T2 M. tuberculosis
JC2 F 1 week 53 T1 M. tuberculosis
JC3 M 6 weeks M. tuberculosis (deletion analysis)
JC4 F 5 weeks 61 LAM10_CAM M. tuberculosis
JC5 M 3 months 774 T1 M. tuberculosis
JC6 F 1 year, 3 months 61 LAM10_CAM M. tuberculosis
JC7 M 4 months M. africanum (deletion analysis)
JC8 F 3 months Not in SpolDB4 New strain (probably
evolved from LAM10_CAM)
M. tuberculosis
JC9 F 6 months 358 T1 M. tuberculosis
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master mix system from Qiagen was used for the PCRs, with
primers previously described by Warren and colleagues.19
The PCR mixture was a multiplex reaction, with each PCR
reaction containing 1 ml of DNA template, 5 ml Q-buffer,
12.5 ml multiplex master mix (Qiagen), and 0.5 ml of each
primer (50 pmol/ml). The total volume of the reaction was
made up to 25 ml with water. The reaction was allowed to run
for 15 min at 95 8C, followed by 45 cycles at 94 8C for 1 min,
62 8C for 1 min, and 72 8C for 1 min. After the last cycle, the
samples were incubated at 72 8C for 10 min. Products were
visualized by electrophoresis on 3% agarose gels.
The positive controls included a known M. bovis isolate
(AN5) and a known M. tuberculosis isolate provided by the
Medical Research Council, Center for Molecular and Cellular
Biology, Stellenbosch University, Cape Town, South Africa,
whilst the negative controlwaswater. The resulting gel images
were analyzed on the basis of their alignment on the gel (i.e.,
same band size with either of the controls). The RD9 deletion
analysis was done to discriminate M. tuberculosis from other
Mycobacterium tuberculosis complex (MTC). Those with a
deletion at this region were further investigated with primers
targeting the RD4 region and this discriminated M. bovis from
the other members of the MTC. Primers targeting the RD1mic
and RD2seal regions were later used to confirm the presence of
M. africanum relative toMycobacterium pinnipedii andMyco-
bacterium microti as described by Warren and colleagues.19
Results
One hundred and ninety-two children were recruited into the
study, comprising 95 males and 97 females, aged 3 days to 3
years. Thirty children had AFB present in their stool speci-
mens. Mycobacterial culture of stool samples from the 30Figure 1 Spoligotype profile of pediatric patients with a positchildren yielded a growth in nine (30%). Spoligotyping and
deletion analysis confirmed these isolates as M. tuberculosis
complex (eightM. tuberculosis and oneM. africanum; Table 1
and Figure 1). The patients with the positive stool mycobac-
terial cultures included three males and six females, with
ages ranging from 1 week to 15 months (Table 1).
Discussion
The diagnosis of TB in pediatric patients is often based on
case definitions that incorporate signs and symptoms of TB,
suggestive chest radiograph, positive tuberculin skin test,
and contact with an active TB patient. It is less frequently
based on laboratory isolation of M. tuberculosis. Existing
algorithms, however, have serious shortcomings, and the
development of reliable and widely applicable algorithms
is a high research priority.
In this study, we diagnosed M. tuberculosis in 27% (8/30)
and M. africanum in 3% (1/30) of children who had AFB-
positive stool specimens. Other investigators have diagnosed
tuberculosis based on isolation of M. tuberculosis from stool
specimens, but in different patient populations. Mwachari
et al.20 cultured M. tuberculosis from the stools of 10 (13%)
HIV-infected adults with chronic diarrhea in Kenya. Mana-
tsathit et al.21 also foundM. tuberculosis in the stools of eight
(18%) adult AIDS patients in Thailand. In South Africa, 8% and
5% of 66 children with suspected PTB had stool specimens
that were AFB-positive and M. tuberculosis culture-positive,
respectively.9 In that study, AFB were identified only in the
stools of children who had PTB that was confirmed with
positive gastric aspirates, but stool testing was less sensitive
than gastric aspirates overall. Our study is unique because
the study population included apparently well children who
were brought to the clinic for routine immunization. None ofive culture result for Mycobacterium tuberculosis complex.
Mycobacterium in stools from children, Nigeria 743the children had diarrhea, but four had cough, although
clinical data were not collected prospectively in all children.
The yield might be higher in children clinically suspected of
having TB.
Some findings of this study provide potentially important
epidemiological information. Firstly, M. tuberculosis has
been implicated in most cases of TB in children; however,
we found a case of M. africanum. This is, to our knowledge,
the first published isolation of M. africanum in the stools of a
Nigerian child. Cases of TB caused byM. africanum have been
previously reported in adults from Nigeria22,23 and other
African countries.24,25 In Cameroon, there has been a decline
in the prevalence of M. africanum;24 however more cases
have recently been observed in HIV/AIDS patients in The
Gambia25 and Nigeria.23 Secondly, one of the M. tuberculosis
strains cultured in this study (isolate from patient JC8) has
not been previously reported in the SpolDB4 database, which
contains a comprehensive listing of the M. tuberculosis
strains around the world (Figure 1). This implies the possible
circulation of poorly characterized or emerging M. tubercu-
losis strains in Nigeria.
This study should be interpreted in the context of its
limitations. Since we did not have records of HIV testing in
the mothers or children, we were unable to correlate our
findings with the HIV infection status of the subjects. Also,
full contact tracing was possible only in some of the children
with positive stool tests, seriously constricting our ability to
comment on the public health significance of the results. Our
data cannot be extrapolated to older children because the
oldest subject in this study was 3 years old. Finally, we do not
have complete data on the subsequent clinical course of the
patients. Despite these limitations, our findings add to the
evidence that directed stool studies may be useful in pedia-
tric TB diagnosis.
In conclusion, we have described the isolation of M.
tuberculosis from the stools of a significant proportion of
apparently well children attending the University of Ibadan
Health Services Clinic. We have also described the first
isolation of M. africanum from the stools of a Nigerian child.
The problematic nature of diagnosing TB disease in this age
group justifies further investigation of the diagnostic poten-
tial of stool specimens and other readily obtainable speci-
mens, perhaps using more sensitive techniques. The
limitations of such testing and the population for which it
would be applicable are also fertile areas for clinical and
laboratory studies.
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